Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome

Background  Nephrotic syndrome (NS) is associated with an increased risk of thromboembolic events (TEs), due to hemostatic derangements. The use of direct oral anticoagulants (DOACs) in the prevention of TE has not been studied intensively in patients suffering from NS. Methods  The method included...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Meerhaeghe, Tess, Cez, Alexandre, Dahan, Karine, Esteve, Emmanuel, Elalamy, Ismail, Boffa, Jean Jacques, Ponlot, Eleonore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546608/
https://www.ncbi.nlm.nih.gov/pubmed/36299618
http://dx.doi.org/10.1055/a-1920-6224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546608/
https://www.ncbi.nlm.nih.gov/pubmed/36299618
http://dx.doi.org/10.1055/a-1920-6224

Ejemplares similares